CHMP issues positive opinion to expand EU label for Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

CHMP issues positive opinion to expand EU label for Gilenya

Postby MSUK » Tue Apr 29, 2014 3:46 am

CHMP issues positive opinion to expand EU label for Gilenya in RRMS

Swiss drug giant Novartis said that the Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion to expand the EU label for Gilenya (fingolimod) in relapsing remitting multiple sclerosis or RRMS..... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service